Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deutsche Gesellschaft für Humanplasma (DGH) is a specialized German healthcare company focused on the collection and provision of high-quality human plasma for the manufacture of essential biopharmaceuticals. Operating a network of modern plasma donation centers across Germany, the company serves as a critical link in the supply chain for plasma-derived medicinal products. DGH adheres to rigorous international quality and safety standards, including Good Manufacturing Practice (GMP), to ensure the integrity and safety of the collected plasma. Their output supports the production of life-saving therapies for patients with rare diseases, immune system disorders, and emergency medical needs. The company is committed to promoting plasma donation awareness and maintaining high medical standards for donor care and product quality.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deutsche Gesellschaft für Humanplasma.